Annual revenue:
$528.29M+$128.94M(+32.29%)Summary
- As of today (June 2, 2025), FOLD annual revenue is $528.29 million, with the most recent change of +$128.94 million (+32.29%) on December 31, 2024.
- During the last 3 years, FOLD annual revenue has risen by +$222.78 million (+72.92%).
- FOLD annual revenue is now at all-time high.
Performance
FOLD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$125.25M-$24.46M(-16.34%)Summary
- As of today (June 2, 2025), FOLD quarterly revenue is $125.25 million, with the most recent change of -$24.46 million (-16.34%) on March 31, 2025.
- Over the past year, FOLD quarterly revenue has increased by +$14.85 million (+13.45%).
- FOLD quarterly revenue is now -16.34% below its all-time high of $149.71 million, reached on December 31, 2024.
Performance
FOLD Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$543.14M+$14.85M(+2.81%)Summary
- As of today (June 2, 2025), FOLD TTM revenue is $543.14 million, with the most recent change of +$14.85 million (+2.81%) on March 31, 2025.
- Over the past year, FOLD TTM revenue has increased by +$119.65 million (+28.25%).
- FOLD TTM revenue is now at all-time high.
Performance
FOLD TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
FOLD Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.3% | +13.4% | +28.3% |
| 3 y3 years | +72.9% | +59.1% | +70.9% |
| 5 y5 years | +189.9% | +106.9% | +160.2% |
FOLD Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.9% | -16.3% | +59.1% | at high | +70.9% |
| 5 y | 5-year | at high | +189.9% | -16.3% | +106.9% | at high | +160.2% |
| alltime | all time | at high | >+9999.0% | -16.3% | >+9999.0% | at high | >+9999.0% |
FOLD Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $125.25M(-16.3%) | $543.14M(+2.8%) |
| Dec 2024 | $528.29M(+32.3%) | $149.71M(+5.8%) | $528.29M(+7.0%) |
| Sep 2024 | - | $141.52M(+11.7%) | $493.67M(+8.3%) |
| Jun 2024 | - | $126.67M(+14.7%) | $455.65M(+7.6%) |
| Mar 2024 | - | $110.40M(-4.1%) | $423.49M(+6.0%) |
| Dec 2023 | $399.36M(+21.3%) | $115.08M(+11.2%) | $399.36M(+7.2%) |
| Sep 2023 | - | $103.50M(+9.5%) | $372.37M(+6.2%) |
| Jun 2023 | - | $94.50M(+9.5%) | $350.56M(+4.1%) |
| Mar 2023 | - | $86.27M(-2.1%) | $336.79M(+2.3%) |
| Dec 2022 | $329.23M(+7.8%) | $88.10M(+7.8%) | $329.23M(+1.8%) |
| Sep 2022 | - | $81.69M(+1.2%) | $323.29M(+0.7%) |
| Jun 2022 | - | $80.73M(+2.6%) | $321.14M(+1.0%) |
| Mar 2022 | - | $78.72M(-4.2%) | $317.83M(+4.0%) |
| Dec 2021 | $305.51M(+17.1%) | $82.15M(+3.3%) | $305.51M(+3.9%) |
| Sep 2021 | - | $79.55M(+2.8%) | $293.93M(+4.3%) |
| Jun 2021 | - | $77.41M(+16.6%) | $281.82M(+5.6%) |
| Mar 2021 | - | $66.40M(-5.9%) | $266.76M(+2.3%) |
| Dec 2020 | $260.89M(+43.2%) | $70.57M(+4.6%) | $260.89M(+6.2%) |
| Sep 2020 | - | $67.44M(+8.2%) | $245.61M(+8.2%) |
| Jun 2020 | - | $62.35M(+3.0%) | $226.94M(+8.7%) |
| Mar 2020 | - | $60.52M(+9.5%) | $208.72M(+14.5%) |
| Dec 2019 | $182.24M(+99.7%) | $55.29M(+13.4%) | $182.24M(+14.2%) |
| Sep 2019 | - | $48.77M(+10.5%) | $159.59M(+21.4%) |
| Jun 2019 | - | $44.13M(+29.6%) | $131.42M(+21.0%) |
| Mar 2019 | - | $34.05M(+4.3%) | $108.59M(+19.0%) |
| Dec 2018 | $91.25M(+147.1%) | $32.64M(+58.5%) | $91.25M(+24.4%) |
| Sep 2018 | - | $20.60M(-3.3%) | $73.33M(+15.3%) |
| Jun 2018 | - | $21.31M(+27.6%) | $63.61M(+28.6%) |
| Mar 2018 | - | $16.70M(+13.4%) | $49.46M(+33.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $36.93M(+644.9%) | $14.73M(+35.5%) | $36.93M(+47.5%) |
| Sep 2017 | - | $10.87M(+51.9%) | $25.03M(+53.7%) |
| Jun 2017 | - | $7.16M(+71.7%) | $16.29M(+78.4%) |
| Mar 2017 | - | $4.17M(+47.3%) | $9.13M(+84.1%) |
| Dec 2016 | $4.96M(+305.1%) | $2.83M(+33.1%) | $4.96M(+133.1%) |
| Sep 2016 | - | $2.13M(+625.9%) | $2.13M(+37.4%) |
| Dec 2014 | $1.22M(+237.2%) | - | - |
| Sep 2014 | - | $293.00K(-38.3%) | $1.55M(+19.6%) |
| Jun 2014 | - | $475.00K(+4.2%) | $1.29M(+58.0%) |
| Mar 2014 | - | $456.00K(+40.7%) | $819.00K(+125.6%) |
| Dec 2013 | $363.00K(-98.0%) | $324.00K(+730.8%) | $363.00K(+830.8%) |
| Sep 2013 | - | $39.00K(-99.6%) | $39.00K(-99.9%) |
| Dec 2012 | $18.41M(-14.1%) | - | - |
| Jun 2012 | - | $10.64M(+36.8%) | $29.84M(+28.4%) |
| Mar 2012 | - | $7.77M(+38.1%) | $23.24M(+8.4%) |
| Dec 2011 | $21.43M(+2224.7%) | $5.63M(-2.9%) | $21.43M(+28.1%) |
| Sep 2011 | - | $5.80M(+43.5%) | $16.73M(+53.1%) |
| Jun 2011 | - | $4.04M(-32.3%) | $10.93M(+58.7%) |
| Mar 2011 | - | $5.97M(+547.1%) | $6.89M(+647.1%) |
| Dec 2010 | $922.00K(-98.6%) | $922.00K(-98.1%) | $922.00K(-98.6%) |
| Dec 2009 | $64.36M(+330.0%) | $49.48M(+907.0%) | $64.36M(+234.8%) |
| Sep 2009 | - | $4.91M(-8.4%) | $19.23M(+7.0%) |
| Jun 2009 | - | $5.36M(+16.4%) | $17.96M(+9.5%) |
| Mar 2009 | - | $4.61M(+6.0%) | $16.41M(+9.7%) |
| Dec 2008 | $14.97M(+739.0%) | $4.34M(+18.9%) | $14.96M(+40.9%) |
| Sep 2008 | - | $3.65M(-4.0%) | $10.62M(+52.4%) |
| Jun 2008 | - | $3.81M(+20.5%) | $6.97M(+120.5%) |
| Mar 2008 | - | $3.16M | $3.16M |
| Dec 2007 | $1.78M | - | - |
FAQ
- What is Amicus Therapeutics annual revenue?
- What is the all time high annual revenue for Amicus Therapeutics?
- What is Amicus Therapeutics annual revenue year-on-year change?
- What is Amicus Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly revenue year-on-year change?
- What is Amicus Therapeutics TTM revenue?
- What is the all time high TTM revenue for Amicus Therapeutics?
- What is Amicus Therapeutics TTM revenue year-on-year change?
What is Amicus Therapeutics annual revenue?
The current annual revenue of FOLD is $528.29M
What is the all time high annual revenue for Amicus Therapeutics?
Amicus Therapeutics all-time high annual revenue is $528.29M
What is Amicus Therapeutics annual revenue year-on-year change?
Over the past year, FOLD annual revenue has changed by +$128.94M (+32.29%)
What is Amicus Therapeutics quarterly revenue?
The current quarterly revenue of FOLD is $125.25M
What is the all time high quarterly revenue for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly revenue is $149.71M
What is Amicus Therapeutics quarterly revenue year-on-year change?
Over the past year, FOLD quarterly revenue has changed by +$14.85M (+13.45%)
What is Amicus Therapeutics TTM revenue?
The current TTM revenue of FOLD is $543.14M
What is the all time high TTM revenue for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM revenue is $543.14M
What is Amicus Therapeutics TTM revenue year-on-year change?
Over the past year, FOLD TTM revenue has changed by +$119.65M (+28.25%)